ISSN Print: 2277-4343
Article: ROLE OF VIRECHANA KARMA IN DIABETES MELLITUS TYPE 2: A CLINICAL TRIAL
Article Category: Original Research articles
Author: Tiwari Swati *, Gupta Sanjay, Srivastava Kumar Alok
Abstract: Diabetes is a major public health problem that is approaching epidemic proportions globally. It is the most common endocrine disorder with an increasing global prevalence and incidence. Type 2 diabetes is associated with a ten-year-shorter life expectancy.Diabetes Mellitus is aggravated by and associated with metabolic complications that can subsequently lead to premature death. The available drug therapy has good effects on levels of blood sugar but it has many side effects and also its dose increases with time, while Ayurvedanot only gives efficient results on high blood sugar but also does not have any side effects. On behalf of blood sugar profile and BMI, the evaluation of Virechana Karma(medicated purgation therapy) was done in comparison to modern oral hypoglycemic and well-practiced drug Metformin. Total 40 patients of newly diagnosed cases of Diabetes Mellitus were taken and divided into two groups. As Trial group, 20 patients were given 2 sittings of Virechana Karma with study period of 60 days while in Control Group 20 patients were given tablet Metformin 500 mg O.D. for 60 days. Virechanais found to be more effective than Metformin.75.86% reduction was found in Blood sugar F, 77.59% reduction in Blood sugar PP, 20.00% reduction in HbA1C and 65.00% reduction in BMI was found in Virechanagroup. So, Virechanakarmahas highly significant results in reducing blood sugar levels, HbA1c and BMI along with better follow up results.
Keyword: Diabetes Mellitus Type 2, Endocrine, Madhumeha, Ayurveda, Virechana Karma